fig4
Figure 4. Schematic representation of the mechanism whereby nanomedicines achieve cancer therapeutic efficiency via passive targeting (EPR effect) and active targeting (ligand binding). Adapted from R. Masoudifar et al.[41]. EPR: Enhanced permeability and retention.
